Menu Search
Equities

C Rad AB

CRAD B:STO

C Rad AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)36.60
  • Today's Change-0.80 / -2.14%
  • Shares traded68.45k
  • 1 Year change+18.83%
  • Beta0.9285
Data delayed at least 15 minutes, as of Sep 20 2024 12:16 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in SEK

The one analyst offering a 12 month price target expects C Rad AB share price to rise to 44.00 in the next year from the last price of 37.40.
High17.6%44.00
Med17.6%44.00
Low17.6%44.00

Earnings history & estimates in SEK

On Jul 18, 2024, C Rad AB reported 2nd quarter 2024 earnings of 0.31 per share.
The next earnings announcement is expected on Oct 23, 2024.
Average growth rate+42.49%
C Rad AB reported annual 2023 earnings of 1.36 per share on Feb 08, 2024.
Average growth rate+141.24%
More ▼

Revenue history & estimates in SEK

C-Rad AB (publ) had 2nd quarter 2024 revenues of 129.40m. This bettered the 115.00m estimate of the one analyst covering the company. This was 53.32% above the prior year's 2nd quarter results.
Average growth rate+10.53%
C-Rad AB (publ) had revenues for the full year 2023 of 424.60m. This was 40.92% above the prior year's results.
Average growth rate+74.30%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.